In recent years, the familiar symptoms of the flu might kick us into reaching for at-home testing kits. But on the eve of the ...

New research led by Yale School of Medicine (YSM) advances the goals of creating a diagnostic test and vaccines for ...

Equities researchers at HC Wainwright issued their FY2025 earnings per share estimates for shares of Virax Biolabs Group in a research note issued to investors on Monday, March 31st. HC Wainwright ...

Renier Brentjens, a CAR T-cell pioneer, views armored CAR T-cells as a promising avenue for treating solid tumors and ...

A new business in Lower Paxton Township is looking to help treat men’s health issues. Gameday Men’s Health might sound like ...

Hematologist-oncologist Mateo Mejia Saldarriaga, MD, combines clinical care with research aimed at helping patients with ...

Helix BioPharma is a clinical-stage biopharmaceutical company aiming to turn scientific breakthroughs into real-world solutions for some of the most difficult-to-treat cancers.

Janux Therapeutics' lead drug, JANX007, shows promising prostate cancer results with no serious side effects. Find out why ...

Telix Pharmaceuticals is leveraging its success with Illuccix to build a diversified theranostic platform, driving long-term ...

The first patient with locally advanced rectal cancer has been enrolled in the FORTRESS study which is evaluating the ...

CAR-T therapy for myeloma faces challenges in early-line use due to accessibility, eligibility criteria and long wait times, ...